Marcus Charleston / WESA

The Confluence – where the news comes together is 90.5 WESA’s weekly news program.

Each week reporters, editors and bloggers join veteran journalists, and host, Kevin Gavin. They’ll go behind the headlines, taking an in-depth look at the stories important to the Pittsburgh region.

This week it was announced that beginning in December Pittsburgh will become a one newspaper town. We'll look at the impact the Tribune Review dropping its print edition has on the city's journalism landscape. Health issues are also in the news. We'll  discuss Governor Tom Wolf's urging of state lawmakers to combat PA's opioid epidemic and Mylan CEO Heather Bresch's  Epipen profits testimony on Capitol Hill. Our look ahead, looks back at golf legend Arnold Palmer.  

Liz Reid / 90.5 WESA

A small group of activists delivered five cardboard boxes containing what they said were the signatures of more than 700,000 “outraged citizens” to Mylan Pharmaceuticals Tuesday morning.

About one in 13 children in the United States have a diagnosed food allergy, but according to the Asthma and Allergy Foundation, there are many who remain undiagnosed and unprotected against the risks of a sudden, severe reaction.

PA House Bill 803, which would allow schools to stock and administer epinephrine, is an attempt to protect children with undiagnosed allergies who have reactions at school. Epinephrine is the primary treatment for anaphylaxis, a serious and potentially fatal allergic reaction which can cause throat-swelling, a rash, and a drop in blood pressure.

A Pennsylvania senator is trying to make schools a little safer for children with life threatening allergies.

Pennsylvania Sen. Matt Smith (D-Allegheny County) introduced legislation earlier this month that would require all Pennsylvania schools to maintain a supply of epinephrine auto-injectors, commonly known as EpiPens.

Senate Bill 898 is designed to help students going into anaphylactic shock after experiencing a potentially fatal allergic reaction.